{
    "2021-03-24": [
        [
            {
                "time": "2023-10-18",
                "original_text": "NEOGEN's (NEOG) Earnings Miss Estimates in Q3, Margins Up",
                "features": {
                    "keywords": [
                        "Earnings",
                        "Miss",
                        "Estimates",
                        "Margins",
                        "Up"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-18",
                "original_text": "Abbott (ABT) Nutrition Shows Robust Momentum Amid Pandemic",
                "features": {
                    "keywords": [
                        "Abbott",
                        "Nutrition",
                        "Robust",
                        "Momentum",
                        "Pandemic"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-18",
                "original_text": "The Zacks Analyst Blog Highlights: Abbott Laboratories, AstraZeneca, Booking, Vertex Pharmaceuticals and Yum China",
                "features": {
                    "keywords": [
                        "Zacks",
                        "Analyst",
                        "Blog",
                        "Highlights",
                        "Abbott",
                        "Laboratories",
                        "AstraZeneca",
                        "Booking",
                        "Vertex",
                        "Pharmaceuticals",
                        "Yum",
                        "China"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "technology",
                        "consumer goods"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}